BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

RSPHvsBBHETF Comparison

ETF 1

RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of

US Health Care

+0.07%

Full RSPH fund page

VS

ETF 2

BBH

VanEck Biotech ETF

This fund is part of

US Health Care

+0.07%

Full BBH fund page

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) and VanEck Biotech ETF (BBH) belong to the same industry segment: US Health Care. RSPH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, BBH's top sector exposures are Healthcare. RSPH is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.35% for BBH. RSPH is up 16.48% year-to-date (YTD) with +$57M in YTD flows. BBH performs better with 25.04% YTD performance, and +$31M in YTD flows. Run a side-by-side ETF comparison of RSPH and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

RSPH vs BBH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 09/17/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	RSPH BBH	+3.25%+6.43%	+17.65%+25.77%	+16.48%+25.04%	+28.50%+43.43%	+34.15%+51.24%	+22.20%+11.19%
Flows	RSPH BBH	+$104M+$38M	+$100M+$38M	+$57M+$31M	+$38M+$12M	-$257M-$142M	-$266M-$160M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	RSPH BBH	+20.51%+27.58%	+16.75%+21.87%	+15.89%+20.27%	+16.80%+21.83%
Max drawdown	RSPH BBH	-5.57%-6.32%	-10.87%-10.54%	-16.96%-22.78%	-21.91%-39.16%
Max drawdown duration	RSPH BBH	29d29d	116d150d	434d440d	817d1778d

Trading data

Create an account to view trading data

Join for free

	RSPH	BBH
Last sale 9/17/2026 at 1:30 PM	$36.97	$236.72
Previous close 09/16/2026	$36.78	$231.17
Consolidated volume 09/16/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	RSPH	BBH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/17/2026 at 1:30 PM

Live

Closed

	RSPH	BBH
Last price	$36.97	$236.72
1D performance	+0.52%	+2.40%
AuM	$913.92 M	$498.32 M
E/R	0.4%	0.35%

Characteristics

	RSPH	BBH
Management strategy	Passive	Passive
Provider	Invesco	VanEck
Benchmark	S&P 500 Equal Weight Health Care Index	MVIS US Listed Biotech 25 Index
N° of holdings	59	24
Asset class	Equities	Equities
Trailing 12m distribution yield	Join	Join
Inception date	November 1, 2006	December 20, 2011
ESG	No	No

More RSPH data on Trackinsight

More BBH data on Trackinsight

Exposure

Countries

RSPH

USA

96.6%

Other

3.4%

BBH

USA

87.55%

Other

12.45%

Sectors

RSPH

Healthcare

98.34%

Other

1.66%

BBH

Healthcare

100%

Diversification

RSPH

Total weight of top 15 holdings out of 15

28.14%

BBH

Total weight of top 15 holdings out of 15

85.32%

Top 15 holdings

Data as of July 31, 2026

RSPH

Bio-Techne Corp.

2.10%

IQVIA Holdings, Inc.

2.08%

Veeva Systems, Inc.

1.95%

Charles River Laboratories International, Inc.

1.93%

Mettler-Toledo International, Inc.

1.89%

Baxter International, Inc.

1.87%

DaVita, Inc.

1.86%

Abbott Laboratories

1.86%

Incyte Corp.

1.85%

Thermo Fisher Scientific, Inc.

1.83%

Moderna, Inc.

1.82%

AbbVie, Inc.

1.79%

Universal Health Services, Inc.

1.78%

Regeneron Pharmaceuticals, Inc.

1.77%

Quest Diagnostics, Inc.

1.77%

BBH

Amgen, Inc.

15.97%

Gilead Sciences, Inc.

12.99%

Vertex Pharmaceuticals, Inc.

8.62%

Regeneron Pharmaceuticals, Inc.

7.18%

Revolution Medicines, Inc.

5.29%

IQVIA Holdings, Inc.

5.18%

Natera, Inc.

4.77%

argenx SE

4.58%

Illumina, Inc.

3.62%

Biogen, Inc.

3.41%

BeOne Medicines Ltd.

3.10%

Moderna, Inc.

2.72%

United Therapeutics Corp.

2.68%

Incyte Corp.

2.65%

Alnylam Pharmaceuticals, Inc.

2.56%

Frequently asked questions about RSPH and BBH

How have the RSPH and BBH ETFs performed in 2026?

As of September 17, 2026, RSPH is up 16.48% year-to-date (YTD), while BBH has returned 25.04%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or BBH?

Year-to-date, the RSPH ETF saw +$57M in flows, compared to +$31M for BBH.

Which ETF is more volatile: RSPH or BBH?

Over the past year, RSPH had a volatility of 16.75%, while BBH experienced 21.87%.

Which ETF is bigger: RSPH or BBH?

As of September 17, 2026, RSPH holds $913.92 M in assets under management (AUM), while BBH manages $498.32 M.

What sectors do the RSPH and BBH ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, BBH focuses on Healthcare.

What are the top holdings of the RSPH ETF and BBH ETF?

RSPH top holdings include Bio-Techne Corp., IQVIA Holdings, Inc. and Veeva Systems, Inc.. BBH holds in its top three: Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc..

Which ETF is more diversified: RSPH or BBH?

RSPH holds 59 securities with 28.14% of its assets in the top 15. BBH has 24 securities and a top 15 weight of 85.32%.

Tony's ETF Buyers Guide: Equal-Weight ETFs

May 14, 2024

RSPH

RSPHvsBBHETF Comparison

Invesco S&P 500® Equal Weight Health Care ETF

VanEck Biotech ETF

RSPH vs BBH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the RSPH and BBH ETFs performed in 2026?

As of September 17, 2026, RSPH is up 16.48% year-to-date (YTD), while BBH has returned 25.04%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or BBH?

Year-to-date, the RSPH ETF saw +$57M in flows, compared to +$31M for BBH.

Which ETF is more volatile: RSPH or BBH?

Over the past year, RSPH had a volatility of 16.75%, while BBH experienced 21.87%.

Which ETF is bigger: RSPH or BBH?

As of September 17, 2026, RSPH holds $913.92 M in assets under management (AUM), while BBH manages $498.32 M.

What sectors do the RSPH and BBH ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, BBH focuses on Healthcare.

What are the top holdings of the RSPH ETF and BBH ETF?

RSPH top holdings include Bio-Techne Corp., IQVIA Holdings, Inc. and Veeva Systems, Inc.. BBH holds in its top three: Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc..

Which ETF is more diversified: RSPH or BBH?

RSPH holds 59 securities with 28.14% of its assets in the top 15. BBH has 24 securities and a top 15 weight of 85.32%.

Tony's ETF Buyers Guide: Equal-Weight ETFs

Have you tried our ETF Compare tool?